Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Three-period Crossover Clinical Trial to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

X
Trial Profile

A Randomized, Open-label, Three-period Crossover Clinical Trial to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atovaquone/proguanil (Primary) ; Esomeprazole (Primary) ; Tegoprazan (Primary) ; Vonoprazan (Primary)
  • Indications Bleeding ulcer; Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Jejunal ulcer; Malaria; NSAID-induced ulcer; Peptic ulcer; Reflux oesophagitis; Stress ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 Mar 2023 Results assessing the effect of tegoprazan on the pharmacokinetics of proguanil, compared with vonoprazan or esomeprazole, published in the Clinical Pharmacokinetics.
    • 23 Sep 2021 Status changed from recruiting to completed.
    • 16 Mar 2021 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top